Medicagos plant based COVID vaccine secures first approval in Canada BMS sues XSpray to block Sprycel generic
By, Admin1 min read
Share
Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline (GSK) today announced that Health Canada has granted approval for COVIFENZ
Found this useful? Share it with your team.
Newsletter
Stay ahead with Clival insights
Subscribe to get the latest updates, data releases and industry information — straight to your inbox.
